World Market for Prescription Generic Drugs, 6th Edition

Published by: Kalorama Information

Published: Apr. 1, 2008 - 250 Pages

Table of Contents

TABLE OF CONTENTS

CHAPTER ONE: EXECUTIVE SUMMARY

• Introduction


• Scope and Methodology


• Size and Growth of the Market
  
• Trends Affecting the Market


• Market Outlook

• Industry Development


• Generic Drug Industry Evolution


• FDA Regulation


• Development and Approval Process


• Industry Structure


• Product Distribution


• Patent Expirations

• Product Categories


• Asthma, Bronchodilators and Corticosteroids


• Inhaled Corticosteroids


• Antiasthmatic Agents


• Bronchodilating Agents


• Antihistamines, Decongestants, and Cough Preparations


• Antihistamines


• Decongestants


• Cough Preparations


• Product News


• Market Size and Forecast


• The World Market


• The U.S. vs World Market


• Competitive Analysis

• Product Categories


• Analgesics


• Nonsteroidal Anti-inflammatory Drugs


• Antirheumatics


• Product News


• Market Size and Forecast


• The World Market


• The U.S. vs World Market


• Competitive Analysis

• Product Categories


• General


• Local


• Regional


• Product News


• Market Size and Forecast


• The World Market


• The U.S. vs World Market

• Product Categories


• Systemic Anti-Infectives


• Topical Anti-Infectives


• Product News


• Market Size and Forecast


• The World Market


• The U.S. vs World Market

Competitive Analysis

• Products


• Product News


• Market Size and Forecast


• The World Marke


• The U.S. vs World Market


• Competitive Analysis

• Product Categories


• Positive Inotropic Agents


• Antiadrenergics


• Beta-Adrenergic Blocking Agents


• Vasodilators


• Calcium Channel Blockers


• Angiotensin-Converting Enzyme Inhibitors


• Antiarrhythmics


• Antihyperlipidemic Agents


• Anticoagulants


• Diuretics


• Product News


• Market Size and Forecast


• The World Market


• The U.S. vs. World Market


• Competitive Analysis

• Product Categories


• Antidepressants, Stimulants, and Antipsychotics


• Antidepressants


• Stimulants


• Antipsychotics


• Anticonvulsants, Antispasmodics, and Muscle Relaxants


• Anticonvulsants


• Antispasmodics


• Muscle Relaxants


• Parkinson’s Disease, Myasthenia Gravis, and Multiple Sclerosis


• Parkinson’s Disease


• Myasthenia Gravis


• Multiple Sclerosis


• Sedatives, Hypnotics, and Antianxiety Drugs


• Product News


• Market Size and Forecast


• The World Market


• The U.S. vs World Market


• Competitive Analysis

• Product Categories


• Antidiarrheals


• Antinauseants


• Antispasmodics


• Antiulcer


• Digestants


• Product News


• Market Size and Forecast


• The World Market


• The U.S. vs the World Market


• Competitive Analysis

• Product Categories


• Male and Female Hormones


• Bone Metabolism Regulators


• Corticosteroids


• Diabetes Drugs


• Thyroid Drugs


• Product News


• Market Size and Forecast


• The World Market


• U.S. vs World Market


• Competitive Analysis

• Product Categories


• Ophthalmic Anti-Infectives


• Ophthalmic Anti-Inflammatories and Mast Cell Inhibitors


• Glaucoma Agents


• Product News


• Market Size and Forecast


• The World Market


• U.S. vs World Market


• Competitive Analysis

• Overview


• Total Market Size and Forecast


• Market and Competitive Analysis

• Understanding Hatch-Waxman and Its Shortfalls


• The FDA, Funding and Review Times


• Big Pharma Tactics—Defensive and Offensive


• Authorized Generics


• Generic Biologics


• Medicaid Generic Drug Reimbursement Issues


• The Elderly


• Confusion in Generic Drug Names


• Broadening Generic Horizons


• International Generic Drug Issues


• Indian Drug Makers


• Industry Consolidation


• New Generic Giants


• Patent Issues: Filings and Challenges


• Generic Companies Increasingly Aggressive


• Patent Reform


• Generic Growth: Prescriptions, Approvals, Impact


• Generic Statins Countdown


• Prescription Drug Costs


• Generics Improve Compliance


• Generic Drug Sampling

• Industry Structure and Participants


• Actavis Group


• APOTEX, Inc.


• Aurobindo Pharma, Ltd


• Barr Laboratories, Inc.


• Bedford Laboratories


• Dr Reddy’s Laboratories Limited


• Dragon Pharmaceuticals, Inc.


• Hospira Inc.


• Mylan Laboratories, Inc.


• Orchid Chemicals and Pharmaceuticals, Ltd.


• Par Pharmaceuticals, Inc.


• Perrigo Company


• PLIVA Pharmaceuticals, Inc.


• Ranbaxy Laboratories, Ltd.


• Roxane Laboratories, Inc.


• Sandoz


• Taro Pharmaceutical Industries Ltd.


• TEVA Pharmaceutical Industries, Ltd.


• Watson Pharmaceuticals, Inc.


• United Research Laboratories and Mutual Pharmaceutical Company


• Zydus Pharmaceuticals, Inc.

LIST OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

• Figure 1-1: The World Market for Prescription Generic Drugs Revenues by Segment 2002-201

• 
  Figure 2-1: Abbreviated New Drug Application Review Flow Chart


• 
  Table 2-1: Brand Name Companies with Generic Subsidiaries


• 
  Table 2-2: Number of Best Selling Drugs with Patents Expiring in Years 2006-2012
  Grouped by Treatment Category


• 
  Table 2-3: Best Selling Prescription Drugs with Expected Patent Expiration
  (Year of Expiration, Brand, Manufacturer, Indication, 2007 Revenues) 2006-2012

• 
  Table 3-1: Prescription Allergy and Respiratory ANDA Approvals, 2006-2007


• 
  Table 3-2: The World Market for Prescription Generic Allergy and Respiratory
  Drugs by Type 2002-2012


• 
  Figure 3-1: The World Market for Prescription Generic Allergy and Respiratory
  Drugs, Revenues by Type 2002-2012


• 
  Table 3-3: The World Market for Prescription Generic Allergy and Respiratory
  Drugs, Market Share by Type 2002-2012


• 
  Table 3-4: The World Market for Prescription Generic Allergy and Respiratory
  Drugs, U.S. Revenues and Share 2002-2012


• 
  Figure 3-2: The World Market for Prescription Generic Allergy and Respiratory
  Drugs, Displaying U.S. Revenues 2002-2012


• 
  Table 3.5: The World Market for Prescription Generic Allergy and Respiratory
  Drugs, Revenues and Market Share by Supplier 2007


• 
  Figure 3-3: The World Market for Prescription Generic Allergy and
  Respiratory Drugs, Market Share by Leading Supplier 2005

• 
  Table 4-1: Prescription Generic Analgesic, NSAID, and Antirheumatic ANDA
  Approvals, 2005


• 
  Table 4-2: The World Market for Prescription Generic Analgesics, NSAIDs and Antirheumatic Drugs by Type 2002-2012


• 
  Figure 4-1: The World Market for Prescription Generic Analgesics, NSAIDs, and
  Antirheumatic Drugs, Revenues by Type 2002-2012


• 
  Table 4-3: The World Market for Prescription Generic Analgesics, NSAIDs, and
  Antirheumatic Drugs, Market Share by Type 2002-2012


• 
  Table 4-4: The World Market for Prescription Generic Analgesics, NSAIDs,
  and Antirheumatic Drugs, U.S. Revenues and Share 2002-2012


• 
  Figure 4-2: The World Market for Prescription Generic Analgesics, NSAIDs,
  and Antirheumatic Drugs Displaying U.S. Revenues 2002-2012


• 
  Table 4-5: The World Market for Prescription Generic Analgesics, NSAIDs,
  and Antirheumatic Drugs Revenues and Market Share by Supplier 2007


• 
  Figure 4-3: The World Market for Prescription Generic Analgesics, NSAIDs,
  and Antirheumatic Drugs Market Share by Leading Supplier 2007

• 
  Table 5-1: Prescription Generic Anesthesia Drug ANDA Approvals, 2006


• 
  Table 5-2: The World Market for Prescription Generic Anesthesia Drugs 2002-2012


• 
  Figure 5-1: The World Market for Prescription Generic Anesthesia Drugs Revenues 2002-2012


• 
  Table 5-3: The World Market for Prescription Generic Anesthesia Drugs,
  U.S. Revenues and Share 2002-2012


• 
  Figure 5-2: The World Market for Prescription Generic Anesthesia Drugs
  Displaying U.S. Revenues 2002-2012


• 
  Table 5-4: The World Market for Prescription Generic Anesthesia Drugs,
  Revenues and Market Share by Supplier 2007


• 
  Figure 5-3: The World Market for Prescription Generic Anesthesia Drugs
  Market Share by Leading Supplier 2007

• 
  Table 6-1: Prescription Generic Anti-infective Drug ANDA Approvals, 2005


• 
  Table 6-2: The World Market for Prescription Generic Anti-Infective Drugs by Type 2002-2012


• 
  Figure 6-1: The World Market for Prescription Generic Anti-Infective Drugs, Revenues by Type 2002-2012


• 
  Table 6-3: The World Market for Prescription Generic Anti-Infective Drugs,
  Market Share by Type 2002-2012


• 
  Table 6-4: The World Market for Prescription Generic Anti-Infective Drugs
  U.S. Revenues and Share 2002-2012


• 
  Figure 6-2: The World Market for Prescription Generic Anti-Infective Drugs Displaying U.S. Revenues 2002-2012


• 
  Table 6-5: The World Market for Prescription Generic Anti-Infective Drugs,
  Revenues and Market Share by Supplier 2007


• 
  Figure 6-3: The World Market for Prescription Generic Anti-Infective Drugs
  Market Share by Leading Supplier 2007

• 
  Table 7-1: Prescription Generic Cancer Drug ANDA Approvals 2006-2007


• 
  Table 7-2: The World Market for Prescription Generic Cancer Drugs
  2002-2012


• 
  Figure 7-1: The World Market for Prescription Generic Cancer Drugs
  Revenues 2002-2012


• 
  Table 7-3: The World Market for Prescription Generic Cancer Drugs, U.S. |
  Revenues and Share 2002-2012


• 
  Figure 7-2: The World Market for Prescription Generic Cancer Drugs
  Displaying U.S. Revenues 2002-2012


• 
  Table 7-4: The World Market for Prescription Generic Cancer Drugs,
  Revenues and Market Share by Supplier 2007


• 
  Figure 7-3: The World Market for Prescription Generic Cancer Drugs
  Market Share by Leading Supplier 2007

• 
  Table 8-1: Prescription Generic Cardiovascular Drug ANDA
  Approvals. 2006-2007


• 
  Table 8-2: The World Market for Prescription Generic Cardiovascular
  Drugs by Type 2002-2012


• 
  Figure 8-1: The World Market for Prescription Generic Cardiovascular
  Drugs Revenues by Type 2002-2012


• 
  Table 8-3: The World Market for Prescription Generic Cardiovascular
  Drugs, Market Share by Type 2002-2012


• 
  Figure 8-2: The World Market for Prescription Generic Cardiovascular
  Drugs, Share by Type 2007 and 2012


• 
  Table 8-4: The World Market for Prescription Generic Cardiovascular
  Drugs U.S. Revenues and Share 2002-2012


• 
  Figure 8-3: The World Market for Prescription Generic Cardiovascular
  Drugs Displaying U.S. Revenues 2002-2012


• 
  Table 8-5: The World Market for Prescription Generic Cardiovascular Drugs, Revenues and Market Share by Supplier 2007


• 
  Figure 8-4: The World Market for Prescription Generic Cardiovascular Drugs,
  Market Share by Leading Supplier 2007

• 
  Table 9-1: Prescription Generic Central Nervous System/Psychotherapeutic Drug
  ANDA Approvals 2006-2007

Table 9-2: The World Market for Prescription Generic Central Nervous System Drugs by Type 2002-2012

• 
  
  Figure 9-1: The World Market for Prescription Generic Central Nervous System Drugs Revenues by Type 2002-2012


• 
  Table 9-3: The World Market for Prescription Generic Central Nervous System Drugs, Market Share by Type 2002-2012


• 
  
  Table 9-4: The World Market for Prescription Generic Central Nervous System Drugs, U.S. Revenues and Share 2002-2012


• 
  Figure 9-2 : The World Market for Prescription Generic Central Nervous System Drugs
  Displaying U.S. Revenues 2002-2012


• 
  Table 9-5 : The World Market for Prescription Generic Central Nervous System Drugs,
  Revenues and Market Share by Supplier 2007


• 
  Figure 9-3 : The World Market for Prescription Generic Central Nervous System Drugs,
  Market Share by Leading Supplier 2007

• 
  Table 10-1: Prescription Generic Gastrointestinal Drug ANDA Approvals
  2006-2007


• 
  Table 10-2: The World Market for Prescription Generic Gastrointestinal
  Drugs by Type, 2002-2012


• 
  Figure 10-1: The World Market for Prescription Generic Gastrointestinal
  Drugs Revenues by Type 2002-2012


• 
  Table 10-3: The World Market for Prescription Generic Gastrointestinal
  Drugs, Market Share by Type 2002-2012


• 
  Figure 10-2: The World Market for Prescription Generic Gastrointestinal
  Drugs, Share by Type 2007 and 2012


• 
  Table 10-4: The World Market for Prescription Generic Gastrointestinal
  Drugs, U.S. Revenues and Share 2002-2012


• 
  Figure 10-3: The World Market for Prescription Generic Gastrointestinal
  Drugs, Displaying U.S. Revenues 2002-2012


• 
  Table 10-5: The World Market for Prescription Generic Gastrointestinal
  Drugs, Revenues and Market Share by Supplier 2007


• 
  Figure 10-4: The World Market for Prescription Generic Gastrointestinal
  Drugs, Market Share by Leading Supplier 2007

• 
  Table 11-1: Prescription Generic Hormone Drug ANDA Approvals 2006-2007


• 
  Table 11-2: The World Market for Prescription Generic Hormone Drugs
  by Type 2002-2012


• 
  Figure 11-1: The World Market for Prescription Generic Hormone Drugs
  Revenues by Type 2002-2012


• 
  Table 11-3: The World Market for Prescription Generic Hormone Drugs,
  Market Share by Type 2002-2012


• 
  Figure 11-2: The World Market for Prescription Generic Hormone Drugs
  Share by Type 2007 and 2012


• 
  Table 11-4: The World Market for Prescription Generic Hormone Drugs
  U.S. Revenues and Share 2002-2012


• 
  Figure 11-3: The World Market for Prescription Generic Hormone Drugs
  Displaying U.S. Revenues 2002-2012


• 
  Table 11-5: The World Market for Prescription Generic Hormone Drugs,
  Revenues and Market Share by Supplier 2007


• 
  Figure 11-4: The World Market for Prescription Generic Hormone Drugs
  Market Share by Leading Supplier 2007

• 
  Table 12-1: Prescription Generic Ophthalmic Drug ANDA
  Approvals 2006-2007


• 
  Table 12-2: The World Market for Prescription Generic Ophthalmic
  Drugs by Type 2002-2012


• 
  Figure 12-1: The World Market for Prescription Generic Ophthalmic Drugs
  Revenues by Type 2002-2012


• 
  Table 12-3: The World Market for Prescription Generic Ophthalmic Drugs,
  Market Share by Type 2002-2012


• 
  Table 12-4: The World Market for Prescription Generic Ophthalmic
  Drugs, U.S. Revenues and Share 2002-2012


• 
  Figure 12-2: The World Market for Prescription Generic Ophthalmic Drugs
  Displaying U.S. Revenues 2002-2012


• 
  Table 12-5: The World Market for Prescription Generic Ophthalmic Drugs,
  Revenues and Market Share by Supplier 2007


• 
  Figure 12-3: The World Market for Prescription Generic Ophthalmic Drugs
  Market Share by Leading Supplier 2007

• 
  Table 13-1: The World Market for Prescription Generic Drugs Revenues
  by Segment 2002-2012


• 
  Figure 13-1: The World Market for Prescription Generic Drugs Revenues
  by Segment 2002-2012


• 
  Figure 13-2: The World Market for Generic Drugs Market Share by
  Type 2007 and 2012


• 
  Table 13-2: World Market for Prescription Generic Drugs Revenues
  and Segments of Participation by Leading Player 2007

Abstract

Kalorama Information's World Market for Prescription Generic Drugs, 6th Edition is your guide to this formidable and important participant in the complex world of healthcare. Included are market size and forecast revnues for:

• Allergy and Respiaratory Drugs
• Analgesics, NAIDS, and Antirheumatic Drugs
• Anesthesia Drugs
• Anti-Infectives
• Cancer Drugs
• Cardiovascular Drugs
• Central Nervous System and Psychotherapeutic Drugs
• Gastrointestinal Drugs
• Ophthalmic Drugs

For each drug segment, the report provides:

• Estimated Generic Market Size
• Forecast to 2012
• Recent ANDA Approvals
• World and US Market Share
• Company Profiles

• Legislative Issues
• Big Pharma Tactics
• Authorized Generics
• Generic Biologics
• Medicaid Generic Drug Reimbursement
• The Elderly
• Confusion in Generic Names
• Broadening Generic Horizons
• International Generic Drug Issues
• Indian Drug Makers
• Industry Consolidation
• New Generic Giants
• Patent Issues
• Generic Companies Increasingly Aggressive
• Patent Reform
• Generic Growth
• Generic Statins
• Cost
• Generics Improve Compliance
• Generic Drug Sampling

Marketing executives, business development managers and brand and generic pharmaceutical companies, consultants and investors are among those who will benefit from this report.

Get Full Details About This Report >>

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.